author-photo

Leanne Dyal

Population Health Research Institute

36

Papers

7426

Citations

Citation Trend

Filter By

Papers (21) Sort By

Journal Conference Others

Low-dose rivaroxaban and aspirin among patients with peripheral artery disease: a meta-analysis of the COMPASS and VOYAGER trials.

2021 European Journal of Preventive Cardiology
Show All
- Source
- Cite
- Save
Citations (0)
Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes.

2021 The New England Journal of Medicine
Show All
- Source
- Cite
- Save
Citations (28)
Dulaglutide is cardioprotective with or without background metformin in patients with diabetes and established or high risk for coronary vascular disease. A subgroup analysis of the REWIND Trial

2020 European Heart Journal
Show All
- Source
- Cite
- Save
Citations (3)
Abstract 15586: Burden of Cardiovascular or Fatal Outcomes in People With Type 2 Diabetes and Cardiovascular Risk Factors Treated With Dulaglutide a Post Hoc Analysis From the Rewind Trial

2020 Circulation
Show All
- Source
- Cite
- Save
Citations (0)
Rivaroxaban for Prevention of Covert Brain Infarcts and Cognitive Decline: The COMPASS MRI Substudy.

2020 Stroke
Show All
- Source
- Cite
- Save
Citations (5)
Total cardiovascular or fatal events in people with type 2 diabetes and cardiovascular risk factors treated with dulaglutide in the REWIND trail: a post hoc analysis

2020 Cardiovascular Diabetology
Show All
- Source
- Cite
- Save
Citations (3)
Rivaroxaban and Aspirin in Patients With Symptomatic Lower Extremity Peripheral Artery Disease: A Subanalysis of the COMPASS Randomized Clinical Trial.

2020 JAMA Cardiology
Show All
- Source
- Cite
- Save
Citations (17)
Rivaroxabana e aspirina versus somente aspirina em relação ao risco vascular no estudo COMPASS

2019
Show All
- Source
- Cite
- Save
Citations (0)
Association Between Low-Dose Rivaroxaban With or Without Aspirin and Ischemic Stroke Subtypes: A Secondary Analysis of the COMPASS Trial

2019 JAMA Neurology
Show All
- Source
- Cite
- Save
Citations (25)
818a – Adverse Events Related to Proton Pump Inhibitor Therapy. Results of a Randomized Trial of Pantoprazole Versus Placebo with 53,152 Patient Years of Follow-Up

2019 Gastroenterology
Show All
- Source
- Cite
- Save
Citations (1)